CSPC, Al­pham­ab On­col­o­gy make an ADC deal; Visen’s IPO in Hong Kong

Plus, news about Se­quen­tia Biotech:

CSPC, Al­pham­ab On­col­o­gy ink ADC deal: CSPC Phar­ma­ceu­ti­cal’s JMT-Bio Tech­nol­o­gy said it will pay RMB 400 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA